Insiders · Profile

Column Group IV GP, LP

10% owner at Eikon Therapeutics. Filing since 6 Feb 2026. CIK 0001796356

Company
Date
Role
Action
Shares
Amount
Of holding
3 Sep 2026
10% owner
Bought
89,200
$1.03M
opened
6 Feb 2026
10% owner
Bought
2,117,760
$38.12M
96.5%
2 decisions on file.